ABVC BioPharma Inc. (ABVC)
ABVC trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.9790
-0.08% on the day
Market cap
$26.1M
Nano cap
Revenue · 2024
$510K
+234.3% on 2023
Net income · 2024
-$4.9M
-962.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | ABVC on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001173313 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $510K |
| Net income | -$4.9M |
| Operating income | -$4.7M |
| Net margin | -962.1% |
| Operating margin | -923.3% |
| Revenue growth | +234.3% |
| Cash | $248K |
| Total assets | $7.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 51.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B4 | 2026-08-17 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-03 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-12 |
| Latest current report CURRENT REPORT | 8-K | 2026-08-27 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-09-29 |
Source: SEC EDGAR submissions feed, 794 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IMMP | Immutep Limited | $3.57 | -2.73% | $26.3M |
| ATOS | Atossa Therapeutics Inc. | $2.56 | +7.17% | $25.5M |
| MCRB | Seres Therapeutics Inc. | $2.53 | -5.60% | $25.4M |
| CNTX | Context Therapeutics Inc. | $0.2750 | -9.84% | $25.3M |
| BYSI | BeyondSpring Inc. | $0.6067 | -1.43% | $24.9M |
| IGC | IGC Pharma Inc. | $0.2650 | -3.99% | $27.4M |
| SHPH | Shuttle Pharmaceuticals Holdings Inc. | $5.18 | -4.95% | $24.7M |
| QNTM | Quantum Biopharma Ltd. Class B Subordinate Voting Shares | $2.89 | +2.48% | $24.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier